Oikos Holdings’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
Sell
-3,321,592
Closed -$13.2M 3
2018
Q4
$13.2M Hold
3,321,592
29.74% 2
2018
Q3
$65.6M Hold
3,321,592
56.37% 1
2018
Q2
$105M Buy
3,321,592
+1,575,700
+90% +$50M 64.12% 1
2018
Q1
$64.6M Buy
1,745,892
+400,000
+30% +$14.8M 50.95% 1
2017
Q4
$106M Buy
+1,345,892
New +$106M 61.65% 1